GHK-Cu for wound healing

GHK-Cu for wound healing has one of the strongest pre-clinical records of any peptide covered on this site. The molecule supports wound closure, angiogenesis at the wound site, collagen and elastin deposition during healing, and reduced scarring on healed wounds. The mechanism is well-characterized, the animal data is consistent, and there's some clinical use in chronic wound management. For surgical recovery and acute wound contexts, GHK-Cu is reasonable to consider — with appropriate medical clearance.

The short answer

Why it works — the mechanism

GHK-Cu touches several core wound-healing pathways simultaneously:

• Angiogenesis — promotes new blood vessel formation at the wound site (VEGF, FGF pathways), supporting tissue oxygenation and nutrient delivery
• Fibroblast activation — drives collagen and elastin synthesis during the proliferative phase of healing
• Anti-inflammatory — modulates pro-inflammatory cytokines, supporting transition out of the inflammatory phase
• Antioxidant activity — manages reactive oxygen species generated during injury, reducing collateral tissue damage
• Macrophage modulation — shifts macrophage phenotype toward the M2 (regenerative) polarization
• Stem cell mobilization — supports recruitment of regenerative cells to the wound site
• Matrix remodeling — supports the late-phase remodeling that determines scar quality

This is real wound biology. GHK-Cu doesn't just sit at the surface — it engages with multiple stages of the healing cascade.

What the research shows

The wound-healing literature on GHK-Cu is broad:

• Animal models of full-thickness wounds — accelerated closure with topical or local GHK-Cu
• Animal models of burn injury — improved healing and reduced scarring
• Diabetic wound models — beneficial effects on chronic, slow-healing wounds
• Surgical wound models — improved closure and tensile strength of healed tissue
• Some clinical chronic wound applications — diabetic foot ulcers and pressure ulcers
• Cosmetic dermatology procedures — used post-laser, post-peel, post-microneedling for recovery support

The pre-clinical data is well-replicated. Clinical use exists in chronic wound management contexts, though it's not a first-line standard-of-care therapy.

Routes for wound applications

Three approaches map to different wound situations:

Topical near-site

For surface wounds, post-procedure recovery, and chronic wounds where the affected tissue is at or near the skin surface:

• Apply cosmetic-grade GHK-Cu serum or wound-care formulation directly to the periwound skin
• Avoid direct application to open, oozing tissue without clinical guidance — use on intact skin around the wound
• Pair with standard wound care (cleansing, dressing, infection management)

Peri-wound SubQ

For acute injuries, surgical sites, or deeper wounds where local tissue support is the goal:

• SubQ injection 1–2 inches from the wound or surgical site
• Typical dose 1–3 mg, daily for the first 5–7 days post-event
• Then taper to 2–3x weekly for the next 2–4 weeks
• Coordinate with surgeon if applicable

Systemic SubQ

For broad anti-inflammatory and recovery support across multiple sites or for general post-injury context:

• Standard 1–2 mg SubQ, 2–3x weekly
• Same as the general anti-inflammatory protocol described in GHK-Cu protocol

Surgical recovery

For surgical recovery applications, GHK-Cu is reasonable to consider but should be discussed with the surgeon:

• Coordinate timing. Some surgeons prefer no peptides in the immediate pre-op period to avoid bleeding-risk concerns; restarting post-op is the typical approach
• Coordinate with anticoagulants. GHK-Cu doesn't have major bleeding effects but the angiogenic activity is a consideration
• Avoid in active malignancy contexts. Pro-angiogenic and pro-regenerative effects are theoretically a concern for tumor biology
• Cosmetic and orthopedic surgery — most-reported use cases in the strength community
• Internal/abdominal surgery — defer to surgeon

For comparison, see BPC-157 post-surgery for another peptide commonly used in surgical recovery contexts.

Scar reduction

GHK-Cu's effects on healed wound tissue include:

• Reduced scar thickness (hypertrophic scar models)
• Improved scar elasticity and texture
• Reduced hyperpigmentation in healed scars
• Better collagen alignment in remodeling phase

For atrophic scars (acne scarring), the combination of GHK-Cu plus microneedling is more impactful than either alone. See GHK-Cu with microneedling.

For hypertrophic and keloid-prone scars, GHK-Cu may help reduce scar overgrowth, though the data is more modest than for general scar texture.

What GHK-Cu doesn't replace

GHK-Cu is an adjunct to wound care, not a replacement for it. Standard care still does the heavy lifting:

• Wound cleansing and debridement
• Appropriate dressings
• Infection management and antibiotics if indicated
• Compression, offloading, and other condition-specific care
• Nutrition and protein intake (collagen synthesis is amino-acid-limited)
• Glycemic control in diabetic wound contexts

A clean, properly managed wound treated with adjunctive GHK-Cu does better than the same wound poorly managed regardless of peptide use.

When not to use

• Active infection at the wound site — treat the infection first
• Active malignancy — defer to oncology team
• Wilson's disease or copper sensitivity — contraindicated
• Pre-op window where surgeon has requested no supplements — comply
• Open, deep wounds without medical guidance — get clinical input
• Pediatric burns or significant trauma — emergency medicine, not peptide protocols

Realistic expectations

GHK-Cu accelerates and improves wound healing — it doesn't make wounds heal in days that would otherwise take weeks. The realistic effect is:

• Faster closure by some percentage on the underlying timeline
• Better quality of healed tissue (less scarring, better elasticity)
• Reduced inflammation during the healing process
• Better post-procedure recovery in cosmetic dermatology contexts

The biology works at biology's pace. GHK-Cu shifts the curve favorably; it doesn't replace it.

Related reading

• GHK-Cu for skin
• GHK-Cu topical vs injection
• GHK-Cu with microneedling
• GHK-Cu research evidence